CONFIRMCKD
LIVE

Serial Number

97542834

Owner

PROGNOSTX HEALTH INC.

Attorney

Monte L. Falcoff

Filing Date

Aug 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CONFIRMCKD Trademark

Serial Number: 97542834

CONFIRMCKD is a trademark filed by PROGNOSTX HEALTH INC. on August 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

PROGNOSTX HEALTH INC. (3 trademarks)

6508 OLD FLOYDSBURG ROAD
PEWEE VALLEY, KY 40056-9116

Entity Type: 03

AmDx PrognostX, Inc. (3 trademarks)

6508 Old Floydsburg Road, STE-4, BLDG-2
Pewee Valley, KY 400569116

Entity Type: 03

Trademark Details

Filing Date

August 10, 2022

Registration Date

Not Registered

Goods & Services

Medical diagnostic services relating to prediabetes, diabetes, kidney disease, and hypertension; medical testing services relating to the diagnosis and treatment of disease; Medical services, namely, administering reagent-based tests for others for diagnosis of diseases; Providing medical diagnostic information services for determining medical risk-scores for prediabetes, diabetes, kidney disease, and hypertension using computers, software and algorithms; none of the foregoing relating to drug testing, mental health screening, or homone level testing and screening services

diagnostic kits and instruments primarily comprised of antibodies and medical diagnostic reagents for testing kidney diseases, prediabetes, diabetes, hypertension, dementia, neurological diseases, aging, cardiovascular diseases, gastrointestinal diseases for medical use; testing apparatus being diagnostic kits for medical purposes primarily comprised of reagents for creating assays to capture and detect disease biomarkers, namely, for detecting kidney diseases; none of the foregoing for testing the presence of drugs, alcohol, or toxins and none being test kits comprised of immunohistochemistry reagents and immunodiagnostic preparations

Diagnostic kits and instruments primarily comprised of containers, immunoassay probes and reagent test strips for kidney diseases, prediabetes, diabetes, hypertension, dementia, neurological diseases, aging, cardiovascular diseases, gastrointestinal diseases and medical use; testing apparatus and instruments for medical purposes in the nature of containers, immunoassay probes and reagent test strips used to create assays to capture and detect disease biomarkers, namely, for detecting kidney diseases; none of the foregoing for testing the presence of drugs, alcohol, or toxins and none being test kits comprised of immunohistochemistry reagents and immunodiagnostic preparations or medical diagnostic apparatus for testing protein, peptides, DNA and RNA samples

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 8, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jun 8, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 8, 2026 CNEA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 15, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 9, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 8, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 8, 2024 RCSC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 11, 2024 ASGN
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 11, 2024 RCSC
ASSIGNED TO EXAMINER
Dec 4, 2023 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 13, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 13, 2023 GNSL
SUSPENSION LETTER WRITTEN
Oct 13, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 8, 2023 CNRT
ASSIGNED TO EXAMINER
May 30, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2022 NWOS
NEW APPLICATION ENTERED
Aug 13, 2022 NWAP